Targeted Neutrophil-Mimetic Liposomes Promote Cardiac Repair by Adsorbing Proinflammatory Cytokines and Regulating the Immune Microenvironment

Chen Jing,Song Yanan,Wang Qiaozi,Li Qiyu,Tan Haipeng,Gao Jinfeng,Zhang Ning,Weng Xueyi,Sun Dili,Yakufu Wusiman,Wang Zhengmin,Qian Juying,Pang Zhiqing,Huang Zheyong,Ge Junbo

DOI: https://doi.org/10.1186/s12951-022-01433-6

IF: 10.2

2022-01-01

Journal of Nanobiotechnology

Abstract:Acute myocardial infarction (MI) induces a sterile inflammatory response that may result in poor cardiac remodeling and dysfunction. Despite the progress in anti-cytokine biologics, anti-inflammation therapy of MI remains unsatisfactory, due largely to the lack of targeting and the complexity of cytokine interactions. Based on the nature of inflammatory chemotaxis and the cytokine-binding properties of neutrophils, we fabricated biomimetic nanoparticles for targeted and broad-spectrum anti-inflammation therapy of MI. By fusing neutrophil membranes with conventional liposomes, we fabricated biomimetic liposomes (Neu-LPs) that inherited the surface antigens of the source cells, making them ideal decoys of neutrophil-targeted biological molecules. Based on their abundant chemokine and cytokine membrane receptors, Neu-LPs targeted infarcted hearts, neutralized proinflammatory cytokines, and thus suppressed intense inflammation and regulated the immune microenvironment. Consequently, Neu-LPs showed significant therapeutic efficacy by providing cardiac protection and promoting angiogenesis in a mouse model of myocardial ischemia-reperfusion. Therefore, Neu-LPs have high clinical translation potential and could be developed as an anti-inflammatory agent to remove broad-spectrum inflammatory cytokines during MI and other neutrophil-involved diseases.